Concepedia

Taeko Kubo

TK

Statistics

Publications

5

Citations

129

H-Index

5

Active since

1995

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Taeko Kubo is an author at Sumitomo Dainippon Pharma (Japan) specializing in drug discovery, pharmacy, and pharmacology.

Publications per year

1995–2016

5

Publications

5

Ca2+-independent fusion of secretory granules with phospholipase A2-treated plasma membranes <i>in vitro</i>

Tsuneatsu Nagao, Taeko Kubo, Ritsuko Fujimoto et al. · Biochemical Journal · 1995 · 36 citations

, , +17

4,5-Dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors

Shigeo Ueda, Hideo Terauchi, Akihiro Yano et al. · Bioorganic & Medicinal Chemistry · 2004 · 35 citations

, , +7

Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives

Shigeo Ueda, Hideo Terauchi, Kenji Suzuki et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 26 citations · Full text

, , +6

Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury

Yasunao Inoue, Tomoki Omodani, Ryotaro Shiratake et al. · Bioorganic & Medicinal Chemistry · 2009 · 17 citations · Full text

, , +10

Significance of integrated in silico transmural ventricular wedge preparation models of human non-failing and failing hearts for safety evaluation of drug candidates

Taeko Kubo, Takashi Ashihara, Tadashi Tsubouchi et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 15 citations · Full text

, , +17

1–5 of 5